Cargando…
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
DNA microarrays and RNA-based sequencing approaches are considered important discovery tools in clinical medicine. However, cross-platform reproducibility studies undertaken so far have highlighted that microarrays are not able to accurately measure gene expression, particularly when they are expres...
Autores principales: | Martello, Marina, Solli, Vincenza, Termini, Rosalinda, Kanapari, Ajsi, Remondini, Daniel, Borsi, Enrica, Poletti, Andrea, Armuzzi, Silvia, Taurisano, Barbara, Vigliotta, Ilaria, Mazzocchetti, Gaia, Zamagni, Elena, Merlotti, Alessandra, Tacchetti, Paola, Pantani, Lucia, Rocchi, Serena, Rizzello, Ilaria, Mancuso, Katia, Cavo, Michele, Terragna, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604171/ https://www.ncbi.nlm.nih.gov/pubmed/36293315 http://dx.doi.org/10.3390/ijms232012450 |
Ejemplares similares
-
P860: CIRCULATING MULTIPLE MYELOMA CELLS (CMMCS) AS PROGNOSTIC FACTOR AND MINIMAL RESIDUAL DISEASE MARKER IN MM AND SMOULDERING MM PATIENTS
por: Vigliotta, Ilaria, et al.
Publicado: (2023) -
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
por: Vigliotta, Ilaria, et al.
Publicado: (2022) -
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles
por: Mazzocchetti, G., et al.
Publicado: (2022) -
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma
por: Martello, M., et al.
Publicado: (2022) -
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
por: Mancuso, Katia, et al.
Publicado: (2023)